Constantia Flexibles Group, one of the world’s leading manufacturers of flexible packaging products and labels, surpassed annual sales of two billion euros in 2016 , the first time in its history. The company also achieved record ...
Tags: Constantia Flexibles, packaging
January 29, 2014 How might Lion's next moves affect the Australian dairy industry Food and beverage company Lion has announced that it does not currently intend to sell its shareholding in Victorian dairy company Warrnambool Cheese and ...
Tags: WCB, Lion, Japan K.K, Warrnambool Cheese
Novartis, a Swiss multinational pharmaceutical company, has signed a definitive agreement to divest its blood transfusion diagnostics unit to Spanish company Grifols for $1.675bn. The blood transfusion diagnostics unit became part of ...
Tags: Novartis, blood transfusion
Specialty pharmaceutical company Tris Pharma's generic pharmaceuticals business has launched Dextroamphetamine Sulfate Oral Solution to treat attention deficit disorder with hyperactivity (ADHD) and narcolepsy in the US. Available through ...
Tags: Tris Pharma, Medicine
GlaxoSmithKline Pharmaceuticals in India has reported a net income from operations of Rs6.37bn ($118.06m) for the first quarter ended 31 March 2013 compared to Rs6.28bn ($116.39m) for the first quarter ended 31 March 2012. Net sales for ...
Tags: Glaxosmithkline, Net Income
US based healthcare products provider Covidien has announced the initial filing of a Form 10 Registration Statement by Mallinckrodt with the US Securities and Exchange Commission (SEC) in connection with the firm's plans to separate its ...
Tags: healthcare products, pharmaceuticals business, pharmaceuticals
The US Food and Drug Administration (FDA) has approved Mallinckrodt's Gablofen (baclofen injection) in prefilled syringes. The approval forms part of the company's strategy to develop Gablofen prefilled syringe for reducing preparation ...
The United States Patent Office has issued a patent covering Nuvo Research's compositions and methods of using Pennsaid (diclofenac sodium topical solution) 2.0% w/w (Pennsaid 2% Patent), which will expire on 21 April 2028. Pennsaid is a ...